Allergan agrees to buy Zeltiq for about $2.48 billion

← Homepage

Allergan Plc (AGN. N) on Monday said it would buy Zeltiq Aesthetics Inc (ZLTQ. O) for about $2.48 billion to gain access to its flagship body contouring technology. The Botox maker agreed to pay $56.50 per Zeltiq share, or a premium of 14.4 percent to the company's Friday close.

South Africa's Sibanye secures $2.65 billion finance for Stillwater deal JOHANNESBURG Sibanye Gold Ltd has secured a loan of $2.65 billion to support the acquisition of Stillwater Mining Company, the only U.S. miner of platinum and palladium, the South African company said on Monday.

Drugmaker Ipsen to buy some products from Sanofi for 83 million euros PARIS Drugmaker Ipsen has agreed to buy five consumer healthcare products from bigger French rival Sanofi for 83 million euros ($88 million), in a deal which Ipsen said should boost its profits.

Toshiba prepares to unveil nuclear hole, other perils threaten TOKYO Toshiba Corp will on Tuesday detail a writedown of close to $6 billion after bruising cost overruns at its U.S. nuclear arm, turning investor attention to the Japanese group's efforts to fix that and other balance sheet headaches.